Clindamycin HCl Oral Drops: Product Information (Page 2 of 2)
PHARMACOLOGY
Absorption: Clindamycin hydrochloride is rapidly absorbed from the canine and feline gastrointestinal tract.
Dog Serum Levels:
Serum levels at or above 0.5 μg/mL can be maintained by oral dosing at a rate of 5.0 mg/lb of clindamycin hydrochloride every 12 hours. This same study revealed that average peak serum concentrations of clindamycin occur 1 hour and 15 minutes after oral dosing. The elimination half-life for clindamycin in dog serum was approximately 5 hours. There was no bioactivity accumulation after a regimen of multiple oral doses in healthy dogs.
Cat Serum Levels:
Serum levels at or above 0.5 μg/mL can be maintained by oral dosing at a rate of 5.0 mg/lb of clindamycin hydrochloride every 24 hours. The average peak serum concentration of clindamycin occurs approximately 1 hour after oral dosing. The elimination half-life of clindamycin in feline serum is approximately 7.5 hours. In healthy cats, minimal accumulation occurs after multiple oral doses of clindamycin hydrochloride, and steady-state should be achieved by the third dose.
METABOLISM AND EXCRETION
Extensive studies of the metabolism and excretion of clindamycin hydrochloride administered orally in animals and humans have shown that unchanged drug and bioactive and bioinactive metabolites are excreted in urine and feces. Almost all of the bioactivity detected in serum after Clindamycin Hydrochloride Oral Drops product administration is due to the parent molecule (clindamycin). Urine bioactivity, however, reflects a mixture of clindamycin and active metabolites, especially N-demethyl clindamycin and clindamycin sulfoxide.
ANIMAL SAFETY SUMMARY
Rat and Dog Data: One year oral toxicity studies in rats and dogs at doses of 30, 100 and 300 mg/kg/day (13.6, 45.5 and 136.4 mg/lb/day) have shown clindamycin hydrochloride to be well tolerated. Differences did not occur in the parameters evaluated to assess toxicity when comparing groups of treated animals with contemporary controls. Rats administered clindamycin hydrochloride at 600 mg/kg/day (272.7 mg/lb/day) for six months tolerated the drug well; however, dogs orally dosed at 600 mg/kg/day (272.7 mg/lb/day) vomited, had anorexia, and subsequently lost weight. At necropsy these dogs had erosive gastritis and focal areas of necrosis of the mucosa of the gallbladder.
Safety in gestating bitches or breeding males has not been established.
Cat Data: The recommended daily therapeutic dose range for clindamycin hydrochloride (Clindamycin Hydrochloride Oral Drops) is 11 to 33 mg/kg/day (5 to 15 mg/lb/day) depending on the severity of the condition. Clindamycin hydrochloride (Clindamycin Hydrochloride Oral Drops) was tolerated with little evidence of toxicity in domestic shorthair cats when administered orally at 10x the minimum recommended therapeutic daily dose (11 mg/kg; 5 mg/lb) for 15 days, and at doses up to 5x the minimum recommended therapeutic dose for 42 days.
Gastrointestinal tract upset (soft feces to diarrhea) occurred in control and treated cats with emesis occurring at doses 3x or greater than the minimum recommended therapeutic dose (11 mg/kg/day; 5 mg/lb/day). Lymphocytic inflammation of the gallbladder was noted in a greater number of treated cats at the 110 mg/kg/day (50 mg/lb/day) dose level than for control cats. No other effects were noted. Safety in gestating queens or breeding male cats has not been established.
HOW SUPPLIED
Clindamycin Hydrochloride Oral Drops is available as 20 mL filled in 30 mL bottles (25 mg/mL) supplied in packers containing 12 cartoned bottles with direction labels and calibrated dosing droppers.
CONTACT INFORMATION
To report suspected adverse events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Covetrus® North America at (855) 724-3461 or www.covetrus.com.. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae
STORAGE
Store at controlled room temperature between 20° to 25° C (68° to 77° F) [see USP].
Keep container tightly closed when not in use.
Pkg Insert Rev. 10-22
Manufactured by:
First Priority, Inc., Elgin, IL 60123
www.prioritycare.com
Approved by FDA under ANADA # 200-398
Reorder #014619
Questions? (855) 724-3461
Distributed by:
Covetrus® North America
400 Metro Place North
Dublin, OH 43017
covetrus.com
Label/Carton Rev. AH-014619-L-03 REV: 0123
Lot No. / Exp. Date
20 mL (0.68 fl oz)
CLINDAMYCIN HCL
ORAL DROPS clinamycin hydrochloride liquid | |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
Labeler — Butler Animal health Supply, LLC dba Covetrus North America (603750329) |
Establishment | |||
Name | Address | ID/FEI | Operations |
FIRST PRIORITY INCORPORATED | 179925722 | manufacture |
Revised: 03/2024 Butler Animal health Supply, LLC dba Covetrus North America
VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.
https://vetlabel.com/lib/vet/meds/clindamycin-hcl-oral-drops/page/2/